Press about Movetis

Movetis NV, of Turnhout, Belgium, obtained approval from the European Commission to commercialize Resolor (prucalopride)
Movetis NV, of Turnhout, Belgium, obtained approval from the European Commission to commercialize Resolor ... Read more >
27/10/2009
Neue Arznei, wenn Laxanzien versagen
Movetis hat von der Europäischen Kommission die Zulassung für die Vermarktung seines Produkts Prucalopride ... Read more >
27/10/2009
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride)
Movetis announced that it has obtained approval from the European Commission for the commercialisation ... Read more >
26/10/2009
Belgische Movetis geht an die Börse
Die belgische Movetis will noch vor Jahresende an die Brüsseler Börse. Wie die Tageszeitung "De Standaard" ... Read more >
26/10/2009
EU approval for Movetis' Resolor validates its targeted strategy in GI disorders
Big Pharma has largely eschewed the risk-reward profile associated with many gastrointestinal drugs. ... Read more >
26/10/2009
RSS

Print

 MailMail